The Astute Clinician: Filing High-Value Adverse Drug Event Reports CME/CE

Author Information and Disclosures

Release Date: October 3, 2008Valid for credit through October 3, 2009

Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s) for physicians;
Nurses - 1.0 ANCC contact hours (1.0 contact hours are in the area of pharmacology);
Pharmacists - 1.0 ACPE continuing education credits for pharmacists (0.1 CEUs)

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME/CE Activity


Downloadable Slides
The Astute Clinician: Filing High-Value Adverse Drug Event Reports
Downloadable PowerPoint Slides by Cindy Kortepeter, PharmD & Judith K. Jones, MD, PhD

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.


PhRMA

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Raise awareness of the prevalence of medication errors and adverse drug events
  2. Identify populations, drug classes, and specific circumstances that raise the risk of drug errors and ADEs
  3. Learn strategies to reduce risks of drug errors
  4. Explain the role of surveillance and reporting programs to improve drug safety
  5. Describe the individual clinician's role and responsibilities in managing patients' medications safely and effectively
Authors and Disclosures

Cindy Kortepeter, PharmD
Disclosure: Cindy Kortepeter, PharmD, has disclosed no relevant financial relationships.


Judith K. Jones, MD, PhD
Disclosure: Judith K. Jones, MD, PhD, has disclosed that she has received research grants for epidemiology research from Abbott Laboratories; Allergan; C.B. Fleet Co. Inc.; Cephalon; Genetech, Inc.; Hoffman-LaRoche; and Oxford Pharmaceuticals. Dr. Jones has also disclosed that she has received a research grant for risk management from Bayer Healthcare, and received consulting fees from Bristol-Myers Squibb, Hoffman-LaRoche, Otsuka Pharmaceutical, Quintiles, and sanofi-aventis.


Laurie E. Scudder, MS, NP-C
Disclosure: Laurie E. Scudder, MS, NP-C, has disclosed that she has no relevant financial relationships.


David Danar, MD
Disclosure: David Danar, MD, has disclosed that he owns a small quantity of Pfizer Inc stock.


Christine Wiebe
Disclosure: Christine Wiebe has disclosed no relevant financial relationships.


 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

Medscape is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.0 contact hour(s) of continuing nursing education for RNs and APNs; 1.0 contact hours are in the area of pharmacology.

Contact This Provider

 
ACPE logoMedscape is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Medscape is accredited by the American Council on Pharmacy Education as a provider of continuing pharmacy education. Medscape designates this continuing education activity for 1.0 contact hour(s) (0.1 CEUs) of the American Council on Pharmacy Education (Universal Program Number 461-000-08-055-H01-P).

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.